The Asia and Pacific Alliance to Eliminate Viral Hepatitis
Established in partnership with the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC), the Asia and Pacific Alliance to Eliminate Viral Hepatitis (APAVH) is a global hepatitis B initiative.
This public-private partnership will focus initially on the 41 countries that comprise the WHO Western Pacific and South-East Asia regions (WPRO) and account for 78 percent of the global burden of hepatitis B infection. APAVH will spearhead capacity building to address and prevent hepatitis B and will be guided by five key goals:
The goals of APAVH are:
- Reduce chronic hepatitis B virus (HBV) infection prevalence globally to less than 2 percent in children 0-15 years of age by the year 2015 (by improving and expanding hepatitis B immunization programs).
- Increase access to chronic HBV testing and antiviral treatment worldwide to reduce transmission rates and disease mortality and morbidity.
- Reduce the blood-borne transmission of hepatitis B.
- Advocate for the elimination of discriminatory practices against persons with chronic viral hepatitis in the school and in the workplace.
- Build program sustainability through regional and national hepatitis B advocacy and increased awareness.